Improving blood pressure monitoring in diverse populations
Implementation Strategies for Self-Measured Blood Pressure Monitoring in Racially and Ethnically Diverse Populations
This study is testing different ways to help low-income patients from diverse backgrounds better monitor their blood pressure at home to see which method works best.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 330 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of California, San Francisco Academic / other |
| Locations | 1 site (San Francisco, California) |
| Trial ID | NCT06871462 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates strategies to enhance self-measured blood pressure (SMBP) monitoring among low-income, racially and ethnically diverse patients with hypertension. It employs a hybrid effectiveness-implementation approach, randomizing 330 patients to either a low-intensity or high-intensity implementation strategy. The low-intensity strategy includes basic training on using a blood pressure monitor, while the high-intensity strategy incorporates additional support factors like digital literacy and social support. The study also involves clinic-level implementation strategies to improve clinical support for SMBP data and includes an economic evaluation to guide future dissemination in similar settings.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and older with uncontrolled hypertension receiving primary care at participating clinics.
Not a fit: Patients with conditions complicating remote blood pressure monitoring, such as recent myocardial infarction or pregnancy, may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved blood pressure control and health outcomes for diverse populations with hypertension.
How similar studies have performed: Previous studies have shown promise in implementing self-monitoring strategies for hypertension, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 years old/order * Any sex or gender * Any race or ethnicity * Must be receiving primary care at any of the six enrolled clinics * Have uncontrolled hypertension (BP \>=140/90 mmHg at any two encounters in the previous 18 months, including the most recent encounter prior to enrollment) * Can read and write English, Spanish, or Cantonese * Be able to provide consent * Must own a cell phone that receives SMS or text messages Exclusion Criteria: * Those with conditions that might complicate remote BP monitoring: * Pregnancy (and 12 months postpartum) * Acute myocardial infarction or stroke in the last 12 months * End-stage renal disease on dialysis * Stage D heart failure * Active treatment for cancer (except for nonmelanoma skin cancers) * Pacemaker use * Those with dementia, in hospice care, or with serious behavioral health conditions impeding participation
Where this trial is running
San Francisco, California
- Zuckerberg San Francisco Hospital — San Francisco, California, United States (Recruiting)
Study contacts
- Principal investigator: Elaine Khoong, MD, MS — University of California, San Francisco
- Study coordinator: Cindy Kim
- Email: hyunjin.kim2@ucsf.edu
- Phone: 415-347-6486
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.